T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Expeditors International
EXPD
$24B
| $153M | 0.02% |
2,014,750
-193,331
| -9% | -$14.6M |
|
|
CSFL
527
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $152M | 0.02% |
6,588,431
+3,865,093
| +142% | +$90.7M |
|
528
Towne Bank
TOWN
$3.49B
| $152M | 0.02% |
5,554,514
-119,112
| -2% | -$3.14M |
|
|
PS
529
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $151M | 0.02% |
4,986,019
+1,977,794
| +66% | +$63.5M |
|
530
Guardant Health
GH
$22.2B
| $151M | 0.02% |
1,749,430
+334,218
| +24% | +$25.5M |
|
531
Westlake Corp
WLK
$10.1B
| $151M | 0.02% |
2,171,725
+2,155,695
| +13,448% | +$143M |
|
532
NovoCure
NVCR
$2.05B
| $149M | 0.02% |
2,357,482
+421,235
| +22% | +$21.3M |
|
533
Paylocity
PCTY
$7.73B
| $149M | 0.02% |
1,586,579
+7,130
| +0.5% | +$677K |
|
534
Align Technology
ALGN
$12.4B
| $148M | 0.02% |
539,771
-251,321
| -32% | -$75.9M |
|
535
Iovance Biotherapeutics
IOVA
$3.05B
| $148M | 0.02% |
6,023,903
+2,531,169
| +72% | +$38.1M |
|
536
Matsons
MATX
$6.41B
| $147M | 0.02% |
3,788,298
+311,148
| +9% | +$11.8M |
|
|
WPX
537
DELISTED
WPX Energy, Inc.
WPX
| $147M | 0.02% |
12,772,455
-2,018,636
| -14% | -$25.1M |
|
538
WSFS Financial
WSFS
$4.15B
| $147M | 0.02% |
3,556,105
+171,092
| +5% | +$7.09M |
|
539
Goldman Sachs
GS
$302B
| $146M | 0.02% |
714,631
-27,170
| -4% | -$5.38M |
|
|
SRE.PRB
540
DELISTED
Sempra 6.75% Mandatory Convertible Preferred Stock, Series B
SRE.PRB
| $145M | 0.02% |
1,299,927
-50,807
| -4% | -$5.55M |
|
541
Macerich
MAC
$6.99B
| $145M | 0.02% |
4,333,443
+261,982
| +6% | +$10.3M |
|
542
Rexford Industrial Realty
REXR
$8.11B
| $145M | 0.02% |
3,593,894
+3,553,677
| +8,836% | +$135M |
|
|
OPTU
543
Optimum Communications Inc
OPTU
$227M
| $145M | 0.02% |
5,943,890
-275,190
| -4% | -$6.53M |
|
544
Federal Realty Investment Trust
FRT
$10.2B
| $145M | 0.02% |
1,123,947
-32,538
| -3% | -$4.32M |
|
545
Valmont Industries
VMI
$9.52B
| $144M | 0.02% |
1,132,929
-1,753,910
| -61% | -$219M |
|
|
IBTX
546
DELISTED
Independent Bank Group, Inc.
IBTX
| $143M | 0.02% |
2,607,532
+72,475
| +3% | +$3.94M |
|
547
AGCO
AGCO
$7.11B
| $143M | 0.02% |
1,846,517
-161,142
| -8% | -$11.5M |
|
|
OPLN
548
Openlane
OPLN
$4.34B
| $142M | 0.02% |
5,664,232
-4,870,262
| -46% | -$105M |
|
549
Cal-Maine
CALM
$3.86B
| $141M | 0.02% |
3,382,598
-141,511
| -4% | -$5.82M |
|
|
TGI
550
DELISTED
Triumph Group
TGI
| $141M | 0.02% |
6,151,267
+23,455
| +0.4% | +$504K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.